COX-2 in cardiovascular disease.
Bishop-Bailey
David
D
Mitchell
Jane A
JA
Warner
Timothy D
TD
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D017544:Aortic Aneurysm, Abdominal / Q000209:etiology* / Q000517:prevention & control; D000068579:Celecoxib; D051545:Cyclooxygenase 1 / Q000502:physiology; D051546:Cyclooxygenase 2 / Q000502:physiology*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D011464:Epoprostenol / Q000096:biosynthesis; D051379:Mice; D011720:Pyrazoles / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000804:Angiotensin II; D011464:Epoprostenol; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D000068579:Celecoxib